Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Non Operating Income (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Non Operating Income data on record, last reported at $820000.0 in Q4 2025.

  • For Q4 2025, Non Operating Income fell 6.39% year-over-year to $820000.0; the TTM value through Dec 2025 reached $4.2 million, up 55.61%, while the annual FY2025 figure was $4.2 million, 55.61% up from the prior year.
  • Non Operating Income reached $820000.0 in Q4 2025 per PLSE's latest filing, down from $982000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $1.2 million in Q1 2025 and bottomed at -$517000.0 in Q2 2021.
  • Average Non Operating Income over 5 years is $373684.2, with a median of $343000.0 recorded in 2024.
  • Peak YoY movement for Non Operating Income: crashed 7433.33% in 2022, then soared 5000.0% in 2023.
  • A 5-year view of Non Operating Income shows it stood at -$6000.0 in 2021, then plummeted by 7433.33% to -$452000.0 in 2022, then surged by 232.74% to $600000.0 in 2023, then surged by 46.0% to $876000.0 in 2024, then decreased by 6.39% to $820000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $820000.0 in Q4 2025, $982000.0 in Q3 2025, and $1.1 million in Q2 2025.